WallStreetZenWallStreetZen

NASDAQ: ROIV
Roivant Sciences Ltd Stock Forecast, Predictions & Price Target

Analyst price target for ROIV

Based on 10 analysts offering 12 month price targets for Roivant Sciences Ltd.
Min Forecast
$12.00+3.45%
Avg Forecast
$16.50+42.24%
Max Forecast
$23.00+98.28%

Should I buy or sell ROIV stock?

Based on 10 analysts offering ratings for Roivant Sciences Ltd.
Strong Buy
Strong Buy
7 analysts 70%
Buy
2 analysts 20%
Hold
1 analysts 10%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ROIV stock forecasts and price targets.

ROIV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-15
lockedlocked$00.00+00.00%2024-02-14
lockedlocked$00.00+00.00%2024-01-05
lockedlocked$00.00+00.00%2024-01-02
lockedlocked$00.00+00.00%2023-12-12
Guggenheim
Top 11%
90
Strong BuyMaintains$16.00+37.93%2023-11-15
JP Morgan
Top 44%
57
Strong BuyMaintains$15.00+29.31%2023-11-14
Goldman Sachs
Top 20%
81
Strong BuyMaintains$16.00+37.93%2023-09-27
Truist Securities
Top 30%
71
Strong BuyReiterates$23.00+98.28%2023-09-26
Cantor Fitzgerald
Top 12%
89
Strong BuyReiterates$15.00+29.31%2023-09-18

1 of 1

Forecast return on equity

Is ROIV forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.62%

Forecast return on assets

Is ROIV forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ROIV revenue forecast

What is ROIV's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$129.6M+5.19%
Avg 2 year Forecast
$211.2M+71.38%
Avg 3 year Forecast
$386.2M+213.35%
ROIV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ROIV revenue growth forecast

How is ROIV forecast to perform vs Biotechnology companies and vs the US market?
Company
44.07%
Industry
52.23%
Market
10%
ROIV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ROIV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ROIV vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ROIV$11.60$16.50+42.24%Strong Buy
ASND$159.40$165.83+4.04%Strong Buy
JAZZ$132.28$191.00+44.39%Buy
APLS$68.47$74.73+9.15%Buy
UTHR$227.03$293.50+29.28%Buy

Roivant Sciences Stock Forecast FAQ

Is Roivant Sciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: ROIV) stock is to Strong Buy ROIV stock.

Out of 10 analysts, 7 (70%) are recommending ROIV as a Strong Buy, 2 (20%) are recommending ROIV as a Buy, 1 (10%) are recommending ROIV as a Hold, 0 (0%) are recommending ROIV as a Sell, and 0 (0%) are recommending ROIV as a Strong Sell.

If you're new to stock investing, here's how to buy Roivant Sciences stock.

What is ROIV's revenue growth forecast for 2024-2026?

(NASDAQ: ROIV) Roivant Sciences's forecast annual revenue growth rate of 44.07% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 52.23%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10%.

Roivant Sciences's revenue in 2024 is $123,241,000.On average, 7 Wall Street analysts forecast ROIV's revenue for 2024 to be $104,467,458,680, with the lowest ROIV revenue forecast at $99,763,735,543, and the highest ROIV revenue forecast at $111,182,573,448. On average, 7 Wall Street analysts forecast ROIV's revenue for 2025 to be $170,198,705,697, with the lowest ROIV revenue forecast at $107,983,364,804, and the highest ROIV revenue forecast at $344,902,090,568.

In 2026, ROIV is forecast to generate $311,202,416,443 in revenue, with the lowest revenue forecast at $189,373,811,410 and the highest revenue forecast at $619,695,578,614.

What is ROIV's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ROIV) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ROIV's Price Target?

According to 10 Wall Street analysts that have issued a 1 year ROIV price target, the average ROIV price target is $16.50, with the highest ROIV stock price forecast at $23.00 and the lowest ROIV stock price forecast at $12.00.

On average, Wall Street analysts predict that Roivant Sciences's share price could reach $16.50 by Feb 15, 2025. The average Roivant Sciences stock price prediction forecasts a potential upside of 42.24% from the current ROIV share price of $11.60.

What is ROIV's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ROIV) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.